Novel Coronavirus (SARS-CoV-2/COVID-19)
Full-dose blood thinner treatments can reduce the need for vital organ support such as ventilation in moderately ill patients hospitalized for COVID-19, according to interim results from a clinical trial announced by the National Institutes of Health.
The novel coronavirus global pandemic upended hospital laboratories when it first emerged.
“We have much to do, much to repair, much to restore, much to heal, much to build … and much to gain.”
President Biden today took a number of actions, including signing a series of executive orders (EOs), aimed at addressing the COVID-19 pandemic.
AHA statement from President and CEO Rick Pollack on President Biden’s Executive Orders.
AHA released its latest issue of the COVID-19 Snapshot, which underscores the dire needs of hospitals and health systems during the deepening public health emergency.
When hundreds of leaders gather virtually February 17–18 for the AHA Rural Health Care Leadership Conference, there will be opportunities for you to make, build and renew connections that help innovate and transform health care, through a pioneering approach toward conferencing.
The Centers for Medicare & Medicaid Services (CMS) today released updated guidance putting in place certain limitations on the hospital survey process, including limiting onsite surveys to immediate jeopardy complaint allegations. The limitations will remain in effect for 30 days with the…
The Food and Drug Administration updated its guidance and webpage on COVID-19 convalescent plasma.
The American Medical Association announced Current Procedural Terminology codes for reporting the single-dose Janssen (Johnson & Johnson) COVID-19 vaccine and its administration on medical claims if the Food and Drug Administration approves the candidate vaccine or authorizes it for emergency…